R1 RCM (RCM) Stock Price, News & Analysis

Company Overview

R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah.

Key Stats

• Today's Range: $14.16 to $14.19
• 50-Day Range: $12.69 to $14.18
• 52-Week Range: $8.87 to $15.26
• Volume: 3.36 million shs
• Average Volume: 3.72 million shs
• Market Capitalization: $5.97 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $15.41
• Consensus Rating: Hold

R1 RCM Stock Analysis - MarketRank™

R1 RCM scored higher than 74% of companies evaluated by MarketBeat, and ranked 113th out of 357 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.1 / 5
• Analyst Rating: Hold

Consensus Rating

R1 RCM has received a consensus rating of Hold. The company's average rating score is 2.28, and is based on 5 buy ratings, 13 hold ratings, and no sell ratings.

Amount of Analyst Coverage

R1 RCM has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for R1 RCM are expected to grow in the coming year, from ($0.24) to $0.13 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of R1 RCM is -177.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of R1 RCM is -177.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

R1 RCM has a P/B Ratio of 2.16. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

10.00% of the float of R1 RCM has been sold short.

Short Interest Ratio / Days to Cover

R1 RCM has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in R1 RCM has recently increased by 5.23%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

R1 RCM does not currently pay a dividend.

Dividend Growth

R1 RCM does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 3.6 / 5
• Environmental Score: -1.33

Percentage of Shares Shorted

10.00% of the float of R1 RCM has been sold short.

Short Interest Ratio / Days to Cover

R1 RCM has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in R1 RCM has recently increased by 5.23%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 0.99

News Sentiment

R1 RCM has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Business Services companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for R1 RCM this week, compared to 6 articles on an average week.

MarketBeat Follows

Only 1 people have added R1 RCM to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, R1 RCM insiders have not sold or bought any company stock.

Percentage Held by Insiders

36.80% of the stock of R1 RCM is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

61.10% of the stock of R1 RCM is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

RCM Stock Analysis - Frequently Asked Questions

How have RCM shares performed this year?

R1 RCM's stock was trading at $10.57 at the start of the year. Since then, RCM shares have increased by 34.2% and is now trading at $14.18.
View the best growth stocks for 2024 here.

How were R1 RCM's earnings last quarter?

R1 RCM Inc. (NASDAQ:RCM) announced its earnings results on Wednesday, August, 7th. The healthcare provider reported ($0.02) EPS for the quarter, beating analysts' consensus estimates of ($0.05) by $0.03. The company's revenue for the quarter was up 12.0% on a year-over-year basis.

Does R1 RCM have any subsidiaries?

R1 RCM subsidiaries include Cloudmed, VisitPay, Cerner RevWorks, SCI Solutions, Intermedix, Accretive Health Mauritius Inc., cGate Health Inc., and others.

How do I buy shares of R1 RCM?

Shares of RCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of R1 RCM own?

Based on aggregate information from My MarketBeat watchlists, some other companies that R1 RCM investors own include NVIDIA (NVDA), JD.com (JD), Baozun (BZUN), Inseego (INSG), BioXcel Therapeutics (BTAI), Marvell Technology (MRVL) and Akoustis Technologies (AKTS).

Company Calendar

• Last Earnings: 8/07/2024
• Today: 10/01/2024
• Next Earnings (Estimated): 11/07/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Management services
• Sub-Industry: Health Care Services
• Current Symbol: NASDAQ:RCM
• Previous Symbol: NYSE:RCM
• CUSIP: 00438V10
• CIK: 1472595
• Web: www.r1rcm.com
• Phone: (312) 324-7820
• Fax: 302-655-5049
• Employees: 30,000
• Year Founded: 2003

Price Target and Rating

• Average Stock Price Target: $15.41
• High Stock Price Target: $19.00
• Low Stock Price Target: $11.00
• Potential Upside/Downside: +8.7%
• Consensus Rating: Hold
• Rating Score (0-4): 2.28
• Research Coverage: 18 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.08)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $3.30 million
• Net Margins: -1.68%
• Pretax Margin: -0.89%
• Return on Equity: -1.44%
• Return on Assets: -0.74%

Debt

• Debt-to-Equity Ratio: 0.77
• Current Ratio: 1.84
• Quick Ratio: 1.84

Sales & Book Value

• Annual Sales: $2.38 billion
• Price / Sales: 2.51
• Cash Flow: $0.69 per share
• Price / Cash Flow: 20.62
• Book Value: $6.56 per share
• Price / Book: 2.16

Miscellaneous

• Outstanding Shares: 421,255,000
• Free Float: 266,233,000
• Market Cap: $5.97 billion
• Optionable: Optionable
• Beta: 0.84